MDT

94.77

-1.6%↓

VEEV

289

+0.99%↑

A

138.2

-0.06%↓

HQY

92.96

-1.67%↓

PHR.US

23.08

+1.81%↑

MDT

94.77

-1.6%↓

VEEV

289

+0.99%↑

A

138.2

-0.06%↓

HQY

92.96

-1.67%↓

PHR.US

23.08

+1.81%↑

MDT

94.77

-1.6%↓

VEEV

289

+0.99%↑

A

138.2

-0.06%↓

HQY

92.96

-1.67%↓

PHR.US

23.08

+1.81%↑

MDT

94.77

-1.6%↓

VEEV

289

+0.99%↑

A

138.2

-0.06%↓

HQY

92.96

-1.67%↓

PHR.US

23.08

+1.81%↑

MDT

94.77

-1.6%↓

VEEV

289

+0.99%↑

A

138.2

-0.06%↓

HQY

92.96

-1.67%↓

PHR.US

23.08

+1.81%↑

Search

West Pharmaceutical Services Inc

Open

SectorHealthcare

264.94 0.84

Overview

Share price change

24h

Current

Min

258.48

Max

265.99

Key metrics

By Trading Economics

Income

42M

132M

Sales

68M

766M

P/E

Sector Avg

39.233

36.442

Dividend yield

0.32

Profit margin

17.202

Employees

10,600

EBITDA

48M

199M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+22.68% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.32%

3.00%

Next Earnings

23 Oct 2025

Next Dividend date

19 Nov 2025

Next Ex Dividend date

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

3.8B

19B

Previous open

264.1

Previous close

264.94

News Sentiment

By Acuity

50%

50%

166 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Oct 2025, 22:33 UTC

Earnings

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

14 Oct 2025, 22:21 UTC

Major Market Movers

Dentsply Sirona Shares Rise After SEC Probe Ends

14 Oct 2025, 19:27 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

14 Oct 2025, 17:56 UTC

Major Market Movers

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

14 Oct 2025, 23:38 UTC

Market Talk

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

14 Oct 2025, 22:12 UTC

Market Talk
Earnings

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

14 Oct 2025, 21:40 UTC

Earnings

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

14 Oct 2025, 21:39 UTC

Earnings

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

14 Oct 2025, 21:38 UTC

Earnings

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

14 Oct 2025, 21:06 UTC

Earnings

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 Oct 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

14 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 Oct 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

14 Oct 2025, 20:50 UTC

Market Talk
Earnings

Health Care Roundup: Market Talk

14 Oct 2025, 20:13 UTC

Earnings

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

14 Oct 2025, 20:01 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

14 Oct 2025, 19:21 UTC

Market Talk
Earnings

Citigroup's Higher Outlook Leaves Questions -- Market Talk

14 Oct 2025, 19:12 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

14 Oct 2025, 19:08 UTC

Market Talk

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

14 Oct 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

14 Oct 2025, 18:59 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

14 Oct 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

14 Oct 2025, 18:58 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

14 Oct 2025, 18:56 UTC

Acquisitions, Mergers, Takeovers

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

14 Oct 2025, 18:46 UTC

Earnings

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

14 Oct 2025, 18:04 UTC

Earnings

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

14 Oct 2025, 18:01 UTC

Market Talk

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

14 Oct 2025, 17:54 UTC

Earnings

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

14 Oct 2025, 17:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 Oct 2025, 17:50 UTC

Market Talk

Lower Dollar Provides Some Strength in Grains -- Market Talk

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

22.68% upside

12 Months Forecast

Average 322 USD  22.68%

High 350 USD

Low 275 USD

Based on 9 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

166 / 371 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat